ArticleBMC immunology2024

NLRP3 (rs10754558) gene polymorphism and tumor necrosis factor alpha as predictors for disease activity and response to methotrexate and adalimumab in psoriasis.

Fatma Z Kamel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.